173 results on '"Sjöblom T"'
Search Results
2. Accurate population-based model for individual prediction of colon cancer recurrence
3. 2307P Loss of CYP2D6 activity sensitizes liver cancer cells to chemotherapy
4. 606P Regional lymph nodes (N+ vs N0) in metastatic colorectal cancer
5. 570P Subclasses of microsatellite-instability colorectal cancer with unique molecular features and immune cell infiltration patterns
6. 572P Neoantigen heterogeneity among subtypes in colorectal cancer
7. 577P Systematically assessing the intratissue microbiota in 937 patients with colorectal cancer
8. Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis
9. PD-22 RAS-mutations in population-based and real-life metastatic colorectal cancer cohorts
10. PD-0538: Rectal cancer: world-wide use of radiotherapy and the importance of more strict lymph node staging
11. Targeted resequencing of candidate genes using selector probes
12. 88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer
13. Smad2 suppresses the growth of Mv1Lu cells subcutaneously inoculated in mice
14. Emerging risk factors of recurrence and overall survival in a Swedish stage I-III colon cancer cohort
15. Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
16. Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer
17. P1.07-021 Multiplex Immune Profiling Identifies Prognostic Importance of the Spatial Co-Localization of Immune Cells in NSCLC
18. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: Clinical impact of recurrent RPS15 mutations
19. PD-012 - Emerging risk factors of recurrence and overall survival in a Swedish stage I-III colon cancer cohort
20. 270TiP - Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
21. Exploiting loss of heterozygosity for allele-selective cancer chemotherapy
22. 460 Direct Detection of TMPRSS2-ERG Rearrangements in Prostate Cancer by Padlock Probes
23. ABCB5 (ATP-binding cassette, sub-family B (MDR/TAP), member 5)
24. Targeted resequencing of candidate genes using selector probes
25. Analysis of genetic changes in small intestinal carcinoid tumors
26. Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis
27. Respiratory symptoms and dermatoses among grinders and brazers of hard metal and stellite blades
28. The spirmatid micronucleus test with the dissection technique detects the germ cell mutagenicity of acrylamide in rat meiotic cells
29. The Helsinki Heart Study: Basic design and randomization procedure.
30. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB
31. Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
32. 114P Molecular alterations in a population-based metastatic colorectal cancer (mCRC) cohort.
33. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
34. 122 - Exploiting loss of heterozygosity for allele-selective cancer chemotherapy.
35. Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers.
36. Prognostic genome and transcriptome signatures in colorectal cancers.
37. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
38. Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.
39. Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma.
40. Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.
41. Automated detection, segmentation and measurement of major vessels and the trachea in CT pulmonary angiography.
42. Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells.
43. Next generation pan-cancer blood proteome profiling using proximity extension assay.
44. Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome.
45. Exact Probability Distribution for the ROC Area under Curve.
46. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.
47. Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.
48. Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions.
49. Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
50. KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.